跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIRABEGRON TEVA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MIRABEGRON TEVA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
MIRABEGRON TEVA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 14, 2024
Approval ID
c2710324a027c67c
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
c2710324a027c67c
Drug Cima Aemps Name
MIRABEGRON TEVA 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
89947
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2024-11-14
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Teva Pharma S.L.U.
Active Ingredients
MIRABEGRON
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 14, 2024
Approval ID
c2710324a027c67c
Type
Standard
Back to CIMA-AEMPS Approvals